Back
Compare AU
Compare ILC vs. IXJ
Compare shares and ETFs on the ASX that you can trade on Pearler.
Overview
When it comes to investing in the Australian stock market, Exchange-Traded Funds (ETFs) are a popular choice. Two well-known options in the Australian Securities Exchange (ASX) are the iShares S&P/ASX 20 ETF (ILC) and the iShares Global Healthcare ETF (IXJ). In this comparison, we'll delve into these ETFs across various dimensions to help you make an informed investment decision.
Community Stats
ILC | IXJ | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 34 | 262 |
Median incremental investment | $850.00 | $1,000.00 |
Median investment frequency | Monthly | Monthly |
Median total investment | $3,162.90 | $1,816.50 |
Average age group | > 35 | 26 - 35 |
Key Summary
ILC | IXJ | |
|---|---|---|
Strategy | ILC.AX was created on 2010-12-06 by iShares. The fund's investment portfolio concentrates primarily on large cap equity. The ETF currently has 708.33m in AUM and 21 holdings. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of the 20 largest Australian securities listed on the ASX. | IXJ.AX was created on 2001-11-13 by iShares. The fund's investment portfolio concentrates primarily on health care equity. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of global biotechnology, healthcare, medical equipment and pharmaceuticals companies and may include large-, mid- or smallcapitalisation stocks |
Top 3 holdings | COMMONWEALTH BANK OF AUSTRALIA (16.88 %) BHP GROUP LTD (13.37 %) CSL LTD (8.31 %) | Eli Lilly and Company (8.25 %) UnitedHealth Group Incorporated (5.81 %) Johnson & Johnson (4.72 %) |
Top 3 industries | Financials (44.17 %) Materials (19.64 %) Consumer Discretionary (8.57 %) | Other (99.98 %) Communication Services (0.02 %) |
Top 3 countries | Australia (98.61 %) United States (1.39 %) | United States (99.97 %) |
Management fee | 0.24 % | 0.46 % |
Key Summary
ILC | IXJ | |
|---|---|---|
Issuer | iShares | iShares |
Tracking index | S&P/ASX 20 - AUD | S&P Global 1200 Healthcare Sector Index - AUD |
Asset class | ETF | ETF |
Management fee | 0.24 % | 0.46 % |
Price | $32.44 | $129.75 |
Size | $709.907 million | $1.304 billion |
10Y return | 32.41 % | 79.88 % |
Annual distribution yield (5Y) | 4.58 % | 1.28 % |
Market | ASX | ASX |
First listed date | 09/12/2010 | 11/03/2009 |
Purchase fee | $6.50 | $6.50 |
Community Stats
ILC | IXJ | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 34 | 262 |
Median incremental investment | $850.00 | $1,000.00 |
Median investment frequency | Monthly | Monthly |
Median total investment | $3,162.90 | $1,816.50 |
Average age group | > 35 | 26 - 35 |
Pros and Cons
ILC | IXJ | |
|---|---|---|
Pros |
|
|
Cons |
|
|
ILC | IXJ |
|---|---|
Higher exposure to AU market | Lower exposure to AU market |
Lower exposure to US market | Higher exposure to US market |
Lower management fee | Higher management fee |
Higher price growth | Lower price growth |
Higher distribution yield | Lower distribution yield |